Document Detail


Experimental animal models of pancreatic cancer (review).
MedLine Citation:
PMID:  10891528     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pancreatic adenocarcinoma is currently the fifth leading cause of cancer-related death in the United States and is largely refractory to conventional therapies. The average survival from diagnosis to death is 4-6 months. The major cause of death is rapid development of metastasis involving the lymph nodes, liver, lungs, or peritoneum. To understand its etiology and eventually to make prevention possible and effective, appropriate carcinogenesis models will certainly help shed more light on the process of pancreatic carcinogenesis and help us understand the effects of environmental and genetic elements on pancreatic cancer development. The development of new treatment strategies to control cancer metastasis is of immediate urgency. Fulfillment of this difficult task relies on our knowledge of the cellular and molecular biology of pancreatic cancer metastasis, and the use of relevant animal models will certainly help define each aspect of this complicated process.
Authors:
Q Shi; K Xie
Related Documents :
12170018 - Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.
16930338 - Pancreatic cancer initially presenting with a pseudocyst at the splenic flexure.
20711688 - A 67-year-old woman with brca 1 mutation associated with pancreatic adenocarcinoma.
21656578 - Effects of mdm2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at...
21271578 - Synchronous second primary tumors in 2,016 head and neck cancer patients: role of sympt...
15298598 - Helicobacter pylori infection in two areas in japan with different risks for gastric ca...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  International journal of oncology     Volume:  17     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2000 Aug 
Date Detail:
Created Date:  2000-08-29     Completed Date:  2000-08-29     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  217-25     Citation Subset:  IM    
Affiliation:
Departments of Gastrointestinal Medical Oncology and Digestive Diseases, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / secondary,  therapy
Animals
Disease Models, Animal*
Humans
Neoplasm Transplantation
Pancreatic Neoplasms / pathology,  therapy*
Tumor Cells, Cultured
Grant Support
ID/Acronym/Agency:
CA16672/CA/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Indications for computed tomography in patients with minor head injury.
Next Document:  Theophylline and cisplatin synergize in down regulation of BCL-2 induction of apoptosis in human gra...